Literature DB >> 25815437

Extracts of Scutellariae Radix inhibit low-density lipoprotein oxidation and the lipopolysaccharide-induced macrophage inflammatory response.

Ohn Soon Kim1, Chang-Seob Seo1, Yeji Kim1, Hyeun-Kyoo Shin1, Hyekyung Ha1.   

Abstract

Traditional herbal formulas made from Scutellariae Radix (SR), the root of Scutellaria baicalensis, have previously been used in the treatment of inflammatory diseases, such as atherosclerosis. The aim of the present study was to investigate the effects of SR on low-density lipoprotein (LDL) oxidation and inflammation in macrophages, which are early events in the development of atherosclerosis. High-performance liquid chromatography photo-diode array analysis was used to obtain a three-dimensional chromatogram of SR. The antioxidative effects of SR were evaluated by determining its scavenging activities against ABTS and DPPH radicals. The inhibitory effect of SR on LDL oxidation was examined using a thiobarbituric acid-reactive substance assay and a relative electrophoretic mobility assay. In addition, the anti-inflammatory effects of SR were evaluated in lipopolysaccharide (LPS)-induced RAW264.7 murine macrophage cells. The results showed that SR exhibited radical-scavenging activities in a dose-dependent manner; in addition, SR attenuated the Cu2+-induced oxidation of LDL as well as significantly inhibited nitric oxide (NO) production and inducible NO synthase (iNOS) expression in LPS-induced RAW264.7 cells. Furthermore, SR induced the protein expression of heme oxygenase-1 (HO-1) in RAW264.7 cells. In conclusion, the results of the present study demonstrated that SR decreased the oxidation of LDL and suppressed inflammatory responses in macrophages, which occurred at least in part via the induction of HO‑1. These results therefore suggested that SR may be a potential therapeutic agent for the treatment of atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25815437     DOI: 10.3892/mmr.2015.3502

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  7 in total

1.  Baicalein, wogonin, and Scutellaria baicalensis ethanol extract alleviate ovalbumin-induced allergic airway inflammation and mast cell-mediated anaphylactic shock by regulation of Th1/Th2 imbalance and histamine release.

Authors:  Thi Tho Bui; Chun Hua Piao; Chang Ho Song; Chang-Hyun Lee; Hee Soon Shin; Ok Hee Chai
Journal:  Anat Cell Biol       Date:  2017-06-27

2.  Antioxidant Activities of Functional Beverage Concentrates Containing Herbal Medicine Extracts.

Authors:  Seon-Joo Park; Mi-Ok Kim; Jung Hoan Kim; Sehyun Jeong; Min Hee Kim; Su-Jin Yang; Jongsung Lee; Hae-Jeung Lee
Journal:  Prev Nutr Food Sci       Date:  2017-03-31

3.  IPSC‑MSC inhibition assessment in Raw 264.7 cells following oxygen and glucose deprivation reveals a distinct function for cardiopulmonary resuscitation.

Authors:  Yi Yu; Dongping Wang; Hui Li; Yujie Liu; Zhao Xiang; Junlin Wu; Xiaoli Jing
Journal:  Mol Med Rep       Date:  2018-04-11       Impact factor: 2.952

4.  Scutellariae Radix and Citri Reticulatae Pericarpium Mixture Regulate PPARγ/RXR Signaling in Reflux Esophagitis.

Authors:  Jin A Lee; Mi-Rae Shin; Hae-Jin Park; Seong-Soo Roh
Journal:  Evid Based Complement Alternat Med       Date:  2022-01-04       Impact factor: 2.629

5.  Targets and Potential Mechanism of Scutellaria baicalensis in Treatment of Primary Hepatocellular Carcinoma Based on Bioinformatics Analysis.

Authors:  Defu Liu; Zhengjun Wang; Li Zhong; Caoyu Xie; Xiaonan Huang; Yaofeng Zhi; Yuzhuo Zhang; Jiaying Liang; Zhenni Shi; Jin Huang; Shuhe Zhang; Jin Zhang; Fuping Ding
Journal:  J Oncol       Date:  2022-02-12       Impact factor: 4.375

6.  Preventive Effects of Velvet Antler (Cervus elaphus) against Lipopolysaccharide-Induced Acute Lung Injury in Mice by Inhibiting MAPK/NF-κB Activation and Inducing AMPK/Nrf2 Pathways.

Authors:  Jui-Shu Chang; Hung-Jen Lin; Jeng-Shyan Deng; Wen-Tzu Wu; Shyh-Shyun Huang; Guan-Jhong Huang
Journal:  Evid Based Complement Alternat Med       Date:  2018-01-02       Impact factor: 2.629

7.  Efficacy and Safety of GHX02 in the Treatment of Acute Bronchitis and Acute Exacerbation of Chronic Bronchitis: A Phase Ⅱ, Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial.

Authors:  Su Won Lee; Yee Ran Lyu; Si Yeon Kim; Won Kyung Yang; Seung Hyung Kim; Ki Mo Kim; Sung-Wook Chae; Weechang Kang; In Chul Jung; Yang Chun Park
Journal:  Front Pharmacol       Date:  2022-01-17       Impact factor: 5.810

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.